CVKD Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. (CVKD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 82% planned / 18% discretionary
Largest single sale: $52.7K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Pham Quang X | Chairman and CEO | Sell 10b5-1 | 7,400 | $3.03 | $22.4K | 98,589 −7% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 9,029 | $3.05 | $27.5K | 105,989 −7.9% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 2,127 | $3.00 | $6.4K | 115,018 −1.8% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 2,277 | $3.20 | $7.3K | 117,145 −1.9% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 9,167 | $3.55 | $32.5K | 119,422 −7.1% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 513 | $3.16 | $1.6K | 128,589 −0.4% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 3,613 | $3.18 | $11.5K | 129,102 −2.7% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell | 3,666 | $3.58 | $13.1K | 132,715 −2.7% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell | 12,996 | $3.94 | $51.2K | 136,381 −8.7% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell | 1,462 | $4.12 | $6.0K | 149,377 −1% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 3,500 | $4.21 | $14.7K | 150,839 −2.3% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 12,992 | $4.06 | $52.7K | 154,339 −7.8% of holding | |
| Pham Quang X | Chairman, CEO and Interim CFO | Sell 10b5-1 | 5,893 | $4.38 | $25.8K | 167,331 −3.4% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 2,064 | $4.42 | $9.1K | 173,224 −1.2% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 3,898 | $4.41 | $17.2K | 175,288 −2.2% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 2,323 | $4.26 | $9.9K | 179,186 −1.3% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 349 | $4.46 | $1.6K | 181,509 −0.2% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 303 | $5.01 | $1.5K | 181,858 −0.2% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 2,989 | $4.93 | $14.7K | 182,161 −1.6% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 1,165 | $5.69 | $6.6K | 194,924 −0.6% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 3,298 | $5.28 | $17.4K | 185,150 −1.8% of holding | |
| Pham Quang X | CEO and Chairman | Sell 10b5-1 | 6,476 | $5.76 | $37.3K | 188,448 −3.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.